These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
149 related articles for article (PubMed ID: 28696844)
1. Comparison of MicroRNAs Mediated in Reactivation of the γ-Globin in β-Thalassemia Patients, Responders and Non-Responders to Hydroxyurea. Hojjati MT; Azarkeivan A; Pourfathollah AA; Amirizadeh N Hemoglobin; 2017 Mar; 41(2):110-115. PubMed ID: 28696844 [TBL] [Abstract][Full Text] [Related]
2. Efficacy of Rapamycin as Inducer of Hb F in Primary Erythroid Cultures from Sickle Cell Disease and β-Thalassemia Patients. Pecoraro A; Troia A; Calzolari R; Scazzone C; Rigano P; Martorana A; Sacco M; Maggio A; Di Marzo R Hemoglobin; 2015; 39(4):225-9. PubMed ID: 26016899 [TBL] [Abstract][Full Text] [Related]
3. Featured Article: Modulation of fetal hemoglobin in hereditary persistence of fetal hemoglobin deletion type-2, compared to Sicilian δβ-thalassemia, by BCL11A and SOX6-targeting microRNAs. Fornari TA; Lanaro C; Albuquerque DM; Ferreira R; Costa FF Exp Biol Med (Maywood); 2017 Feb; 242(3):267-274. PubMed ID: 27591578 [TBL] [Abstract][Full Text] [Related]
4. Hydroxyurea responsiveness in β-thalassemic patients is determined by the stress response adaptation of erythroid progenitors and their differentiation propensity. Pourfarzad F; von Lindern M; Azarkeivan A; Hou J; Kia SK; Esteghamat F; van Ijcken W; Philipsen S; Najmabadi H; Grosveld F Haematologica; 2013 May; 98(5):696-704. PubMed ID: 23100274 [TBL] [Abstract][Full Text] [Related]
5. In vivo and in vitro studies of fetal hemoglobin induction by hydroxyurea in beta-thalassemia/hemoglobin E patients. Watanapokasin Y; Chuncharunee S; Sanmund D; Kongnium W; Winichagoon P; Rodgers GP; Fucharoen S Exp Hematol; 2005 Dec; 33(12):1486-92. PubMed ID: 16338491 [TBL] [Abstract][Full Text] [Related]
6. Hydroxyurea responses and fetal hemoglobin induction in beta-thalassemia/HbE patients' peripheral blood erythroid cell culture. Watanapokasin R; Sanmund D; Winichagoon P; Muta K; Fucharoen S Ann Hematol; 2006 Mar; 85(3):164-9. PubMed ID: 16389564 [TBL] [Abstract][Full Text] [Related]
7. Pharmacological Induction of Human Fetal Globin Gene in Hydroxyurea-Resistant Primary Adult Erythroid Cells. Chou YC; Chen RL; Lai ZS; Song JS; Chao YS; Shen CK Mol Cell Biol; 2015 Jul; 35(14):2541-53. PubMed ID: 25986606 [TBL] [Abstract][Full Text] [Related]
8. miR-30a regulates γ-globin expression in erythoid precursors of intermedia thalassemia through targeting BCL11A. Gholampour MA; Asadi M; Naderi M; Azarkeivan A; Soleimani M; Atashi A Mol Biol Rep; 2020 May; 47(5):3909-3918. PubMed ID: 32406020 [TBL] [Abstract][Full Text] [Related]
9. Impact of ZBTB7A hypomethylation and expression patterns on treatment response to hydroxyurea. Chondrou V; Stavrou EF; Markopoulos G; Kouraklis-Symeonidis A; Fotopoulos V; Symeonidis A; Vlachaki E; Chalkia P; Patrinos GP; Papachatzopoulou A; Sgourou A Hum Genomics; 2018 Oct; 12(1):45. PubMed ID: 30285874 [TBL] [Abstract][Full Text] [Related]
10. MicroRNA-92a-3p-mediated inhibition of BCL11A upregulates γ-globin expression and inhibits oxidative stress and apoptosis in erythroid precursor cells. Li H; Lin R; Li H; Ou R; Wang K; Lin J; Li C Hematology; 2022 Dec; 27(1):1152-1162. PubMed ID: 36178486 [TBL] [Abstract][Full Text] [Related]
11. Quantification of HBG mRNA in primary erythroid cultures: prediction of the response to hydroxyurea in sickle cell and beta-thalassemia. Pecoraro A; Rigano P; Troia A; Calzolari R; Scazzone C; Maggio A; Steinberg MH; Di Marzo R Eur J Haematol; 2014 Jan; 92(1):66-72. PubMed ID: 24112139 [TBL] [Abstract][Full Text] [Related]
12. Drug Repurposing: Hydroxyurea Therapy Improves the Transfusion-Free Interval in HbE/Beta-Thalassemia-Major Patients with the Ghosh D; Panja A; Saha D; Banerjee U; Datta AK; Basu A Genet Test Mol Biomarkers; 2021 Aug; 25(8):563-570. PubMed ID: 34406845 [No Abstract] [Full Text] [Related]
13. MicroRNA-486-3p regulates γ-globin expression in human erythroid cells by directly modulating BCL11A. Lulli V; Romania P; Morsilli O; Cianciulli P; Gabbianelli M; Testa U; Giuliani A; Marziali G PLoS One; 2013; 8(4):e60436. PubMed ID: 23593217 [TBL] [Abstract][Full Text] [Related]
14. Hydroxyurea increases hemoglobin F levels and improves the effectiveness of erythropoiesis in beta-thalassemia/hemoglobin E disease. Fucharoen S; Siritanaratkul N; Winichagoon P; Chowthaworn J; Siriboon W; Muangsup W; Chaicharoen S; Poolsup N; Chindavijak B; Pootrakul P; Piankijagum A; Schechter AN; Rodgers GP Blood; 1996 Feb; 87(3):887-92. PubMed ID: 8562958 [TBL] [Abstract][Full Text] [Related]
15. A review of cis-trans interplay between DNA sequences 5' to the (G)gamma- and beta-globin genes among Hb F-Malta-I heterozygotes/homozygotes and beta-thalassemia homozygotes/compound heterozygotes, and the effects of hydroxyurea on the Hb F/F-erythrocyte; the need for large multicenter trials. Felice AE; Borg J; Pizzuto M; Cassar W; Galdies R; Wettinger SB; Pulis S; Hunter GJ; Caruana MR; Farrugia M; Scerri CA Hemoglobin; 2007; 31(2):279-88. PubMed ID: 17486512 [TBL] [Abstract][Full Text] [Related]
16. MicroRNAs in β-thalassemia. Wang F; Ling L; Yu D Am J Med Sci; 2021 Jul; 362(1):5-12. PubMed ID: 33600783 [TBL] [Abstract][Full Text] [Related]
17. Role of Genomic Biomarkers in Increasing Fetal Hemoglobin Levels Upon Hydroxyurea Therapy and in β-Thalassemia Intermedia: A Validation Cohort Study. Kolliopoulou A; Siamoglou S; John A; Sgourou A; Kourakli A; Symeonidis A; Vlachaki E; Chalkia P; Theodoridou S; Ali BR; Katsila T; Patrinos GP; Papachatzopoulou A Hemoglobin; 2019 Jan; 43(1):27-33. PubMed ID: 31039620 [TBL] [Abstract][Full Text] [Related]
18. Treatment with Hydroxyurea Leads to Fetal Hemoglobin Reactivation through Parsasefat M; Safarpour H; Nomiri S; Miri-Moghaddam E Hemoglobin; 2022 May; 46(3):153-159. PubMed ID: 35506261 [TBL] [Abstract][Full Text] [Related]
19. Role of microRNA in hydroxyurea mediated HbF induction in sickle cell anaemia patients. Kargutkar N; Sawant-Mulay M; Hariharan P; Chandrakala S; Nadkarni A Sci Rep; 2023 Jan; 13(1):369. PubMed ID: 36611033 [TBL] [Abstract][Full Text] [Related]
20. The intrinsic genetic and epigenetic regulator factors as therapeutic targets, and the effect on fetal globin gene expression. Adelvand P; Hamid M; Sardari S Expert Rev Hematol; 2018 Jan; 11(1):71-81. PubMed ID: 29149573 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]